Skip to main content
Premium Trial:

Request an Annual Quote

ImaGenes Certified for NimbleGen DNA Methylation Services

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche NimbleGen said today that it has certified Berlin-based genomics services company ImaGenes to offer its DNA Methylation Analysis arrays.

ImaGenes passed the certification to become a Certified Service Provider for the DNA Methylation Analysis workflow, which is used in identifying novel genetic markers that can be used in diagnostic and prognostic development programs.

In December 2009, Roche certified ImaGenes to offer NimbleGen microarrays for chromatin immunoprecipitation (ChIP-chip) services.

This certification makes ImaGenes the first NimbleGen service provider in Europe with multiple certifications, Roche said.

"We are convinced that ImaGenes will further drive the penetration of Roche NimbleGen's innovative products in the functional genomics market," Roche NimbleGen VP of Marketing Andreas Görtz said in a statement.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.